KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilent Technologies (A) Cash & Equivalents (2016 - 2026)

Agilent Technologies (A) has disclosed Cash & Equivalents for 18 consecutive years, with $1.8 billion as the latest value for Q1 2026.

  • Quarterly Cash & Equivalents rose 19.84% to $1.8 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.8 billion through Jan 2026, up 19.84% year-over-year, with the annual reading at $1.8 billion for FY2025, 34.61% up from the prior year.
  • Cash & Equivalents for Q1 2026 was $1.8 billion at Agilent Technologies, down from $1.8 billion in the prior quarter.
  • The five-year high for Cash & Equivalents was $1.8 billion in Q4 2025, with the low at $1.1 billion in Q4 2022.
  • Average Cash & Equivalents over 5 years is $1.4 billion, with a median of $1.5 billion recorded in 2025.
  • The sharpest move saw Cash & Equivalents fell 29.04% in 2022, then surged 51.0% in 2023.
  • Over 5 years, Cash & Equivalents stood at $1.1 billion in 2022, then skyrocketed by 51.0% to $1.6 billion in 2023, then fell by 16.42% to $1.3 billion in 2024, then soared by 34.61% to $1.8 billion in 2025, then fell by 1.73% to $1.8 billion in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $1.8 billion, $1.8 billion, and $1.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.